Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Knight

Showing results (741-750 of 769) with videos related to

Pageof 77
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|April 22, 2006
Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UKC A Heath, R A Barker, T F G Esmonde, et al.
JCO Oncology Practice|June 16, 2022
Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic MalignancyThomas G Knight, Melissa Aguiar, Myra Robinson, et al.
Annals of Neurology|August 29, 2012
Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob diseaseLynne I McGuire, Alexander H Peden, Christina D Orrú, et al.
Nature|January 26, 1978
Novel treatment for joint inflammationJ T Dingle, J L Gordon, B L Hazleman, et al.
Transplantation and Cellular Therapy|September 27, 2024
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell TransplantationMichael R Grunwald, Wei Sha, Jiaxian He, et al.
Annals of Neurology|June 3, 2010
Validation of diagnostic criteria for variant Creutzfeldt-Jakob diseaseCraig A Heath, Sarah A Cooper, Katy Murray, et al.
Developmental Cell|August 13, 2019
Canonical Wnt5b Signaling Directs Outlying Nkx2.5+ Mesoderm into Pacemaker CardiomyocytesJie Ren, Peidong Han, Xuanyi Ma, et al.
Lancet (London, England)|August 14, 1982
Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patientsA J Clark, R O Adeniyi-Jones, G Knight, et al.
Molecular & Cellular Proteomics : MCP|September 21, 2011
Absolute quantification of the glycolytic pathway in yeast: deployment of a complete QconCAT approachKathleen M Carroll, Deborah M Simpson, Claire E Eyers, et al.
Leukemia & Lymphoma|February 2, 2022
Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF)Aleksander L Chojecki, Kristyn Y DiSogra, Justin Arnall, et al.
Pageof 77

Showing results (741-750 of 769) with videos related to

Sort By:
Pageof 77
Journal of Neurology, Neurosurgery, and Psychiatry|April 22, 2006
Dura mater-associated Creutzfeldt-Jakob disease: experience from surveillance in the UKC A Heath, R A Barker, T F G Esmonde, et al.
JCO Oncology Practice|June 16, 2022
Financial Toxicity Intervention Improves Outcomes in Patients With Hematologic MalignancyThomas G Knight, Melissa Aguiar, Myra Robinson, et al.
Annals of Neurology|August 29, 2012
Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob diseaseLynne I McGuire, Alexander H Peden, Christina D Orrú, et al.
Nature|January 26, 1978
Novel treatment for joint inflammationJ T Dingle, J L Gordon, B L Hazleman, et al.
Transplantation and Cellular Therapy|September 27, 2024
Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell TransplantationMichael R Grunwald, Wei Sha, Jiaxian He, et al.
Annals of Neurology|June 3, 2010
Validation of diagnostic criteria for variant Creutzfeldt-Jakob diseaseCraig A Heath, Sarah A Cooper, Katy Murray, et al.
Developmental Cell|August 13, 2019
Canonical Wnt5b Signaling Directs Outlying Nkx2.5+ Mesoderm into Pacemaker CardiomyocytesJie Ren, Peidong Han, Xuanyi Ma, et al.
Lancet (London, England)|August 14, 1982
Biosynthetic human insulin in the treatment of diabetes. A double-blind crossover trial in established diabetic patientsA J Clark, R O Adeniyi-Jones, G Knight, et al.
Molecular & Cellular Proteomics : MCP|September 21, 2011
Absolute quantification of the glycolytic pathway in yeast: deployment of a complete QconCAT approachKathleen M Carroll, Deborah M Simpson, Claire E Eyers, et al.
Leukemia & Lymphoma|February 2, 2022
Optimization of physician and specialty pharmacy clinical workflow in assessment of risk category and symptom burden in patients with myelofibrosis (MF)Aleksander L Chojecki, Kristyn Y DiSogra, Justin Arnall, et al.
Pageof 77